| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, NIH, Bethesda, Maryland 20892
Retinoids are powerful regulators of epidermal cell growth and differentiation and are widely used in the prevention and treatment of skin disorders and cancers in humans. Since many of the effects of retinoids on cell growth and differentiation are mediated by nuclear retinoid receptors (RARs and RXRs), we were interested in determining RAR and RXR gene expression during mouse skin tumor progression. The two-stage system of mouse skin carcinogenesis was used to generate papillomas and carcinomas, and the different stages of malignant progression (papillomas, differentiated squamous cell carcinomas, undifferentiated squamous cell carcinomas, and spindle cell carcinomas) were characterized in each tumor by specific keratin expression prior to receptor characterization.
Using in situ hybridization analysis, we show that the two major RAR isoforms (
1 and 
1), which account for most of RARs in the skin, were expressed in both the basal and suprabasal layers in mouse epidermis. In contrast, RXR transcripts were compartmentalized to the basal cell layers and concentrated in hair follicles. During skin tumor progression, RAR (1 and 1) transcripts were down-modulated in malignant tumor cells, whereas RXR ( and ß) transcript expression was expanded in papillomas and carcinomas as the number of undifferentiated cells also increased. RXR was not detected in the skin or at any stage during skin tumor progression. Spindle cell tumors lacked markers of the keratinocyte phenotype and lost RAR expression, yet retained expression of RXR and ß. The increased abundance of transcripts for RXRs and decreased presence of RARs in skin tumor progression may favor other nuclear signal transduction pathways requiring RXR for heterodimer formation and contribute to phenotypic progression of cancer cells.
1 To whom requests for reprints should be addressed, at Laboratory of Cellular Carcinogenesis and Tumor Promotion, Building 37, Room 3A17, 37 Convent Drive, MSC 4255, NIH, Bethesda, MD 20892-4255.
Received 1/19/95. Accepted 5/ 2/95.
This article has been cited by other articles:
|
|
 |
|
  P.-L. So, M. A. Fujimoto, and E. H. Epstein Jr. Pharmacologic retinoid signaling and physiologic retinoic acid receptor signaling inhibit basal cell carcinoma tumorigenesis Mol. Cancer Ther., May 1, 2008; 7(5): 1275 - 1284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. B. Janakiram, I. Cooma, A. Mohammed, V. E. Steele, and C. V. Rao -Ionone inhibits colonic aberrant crypt foci formation in rats, suppresses cell growth, and induces retinoid X receptor-{alpha} in human colon cancer cells Mol. Cancer Ther., January 1, 2008; 7(1): 181 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. F. Chen and D. Lohnes Dominant-negative Retinoic Acid Receptors Elicit Epidermal Defects through a Non-canonical Pathway J. Biol. Chem., January 28, 2005; 280(4): 3012 - 3021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Hansen, D. Brown, V. Virador, T. Tanaka, F. Andreola, K. Strain, B. Dancheck, R. Riley, J. M. Arbeit, L. M. De Luca, et al. A PMLRARA Transgene Results in a Retinoid-deficient Phenotype Associated with Enhanced Susceptibility to Skin Tumorigenesis Cancer Res., September 1, 2003; 63(17): 5257 - 5265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-Y. Fan, T. E. Spencer, N. Wang, M. P. Moyer, and R. S. Chapkin Chemopreventive n-3 fatty acids activate RXR{alpha} in colonocytes Carcinogenesis, September 1, 2003; 24(9): 1541 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Soprano and D. R. Soprano Retinoic Acid Receptors and Cancer J. Nutr., December 1, 2002; 132(12): 3809S - 3813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hatoum, M. E. El-Sabban, J. Khoury, S. H. Yuspa, and N. Darwiche Overexpression of retinoic acid receptors alpha and gamma into neoplastic epidermal cells causes retinoic acid-induced growth arrest and apoptosis Carcinogenesis, December 1, 2001; 22(12): 1955 - 1963. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-C. Xu, W. Y. L. Wong, L. Goldberg, S. C. Baer, J. E. Wolf, W. M. Ramsdell, D. S. Alberts, S. M. Lippman, and R. Lotan Progressive Decreases in Nuclear Retinoid Receptors during Skin Squamous Carcinogenesis Cancer Res., June 1, 2001; 61(11): 4306 - 4310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Hansen, C. C. Sigman, F. Andreola, S. A. Ross, G. J. Kelloff, and L. M. De Luca Retinoids in chemoprevention and differentiation therapy Carcinogenesis, July 1, 2000; 21(7): 1271 - 1279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Ross, P. J. McCaffery, U. C. Drager, and L. M. De Luca Retinoids in Embryonal Development Physiol Rev, July 1, 2000; 80(3): 1021 - 1054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Goyette, C. Feng Chen, W. Wang, F. Seguin, and D. Lohnes Characterization of Retinoic Acid Receptor-deficient Keratinocytes J. Biol. Chem., May 26, 2000; 275(22): 16497 - 16505. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
